• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Switch data back Chiesi/Protalix long-acting Fabry drug

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 25, 2021 at 10:32: AM
via Chiesi and Protalix have built the case for their long-acting enzyme replacement therapy (ERT) for Fabry disease PRX-102, as the FDA’s review of the drug continues towards a decision due by 27 April.

article source
 




Top Bottom
Back
Quote